Novartis AG vs Realty Income Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Realty Income Corp trades at $64.95 (market cap $60.78B). The key difference: Novartis AG is far larger — about 4.8× Realty Income Corp's market cap, and Realty Income Corp pays the higher dividend (4.99%). Which is the better fit depends on your goals.
| NVS | O | |
|---|---|---|
Market Cap | $290.25B | $60.78B |
Sector | Health | Real Estate |
52-Week High | $168.62 | $67.56 |
52-Week Low | $113.50 | $55.93 |
Enterprise Value | $330.27B | $90.58B |
Dividend Yield | 3.17% | 4.99% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →